Differentiated thyroid cancer is the most common endocrine malignancy and the incidence is
increasing rapidly worldwide. Appropriate diagnosis and post-treatment monitoring of …

Objectives: To investigate the possible effects of wet-cupping therapy (hijama) on
autoimmune activity and thyroid hormonal profiles of Hashimoto's disease (HD) patients …

Background: The prevalence and clinical significance of de novo detection of anti-
thyroglobulin antibodies (TgAbs) during the follow-up of patients with differentiated thyroid …

Background. Numerous studies reported connection between papillary thyroid carcinoma
(PTC) and thyroid autoantibody in adults, but few of them have investigated whether there is …

Over the past decade, knowledge of the potential role of TSH in the development of
differentiated thyroid cancer has expanded. In addition, the therapeutic role of TSH has …

Thyroid nodules are a common clinical entity, occurring in up to 70% of patients older than
70 years. 1 The preponderance of these lesions represents a benign neoplasm, with only …

Purpose: In this study, we aimed to evaluate ABO blood groups and Rh factor in patients
with thyroid cancer. Methods: Demographical and clinical features, cytological results, ABO …

Background Many reports have supported the relationship between high preoperative TSH
levels and risk of thyroid cancer in nodular thyroid disease (NTD). Objectives We …

Abstract Context: Thyroglobulin antibodies (TgAbs) are surrogate markers of disease
recurrence or persistence in differentiated thyroid cancer (DTC). However, the prognostic …

Abstract Background: Serum thyroglobulin (Tg) is essential to manage differentiated thyroid
carcinoma (DTC). However, Tg determination is affected by circulating Tg antibodies (TgAb) …